Comparison

SARS-CoV-2-IN-14 European Partner

Item no. TMO-T60538-50mg
Manufacturer TargetMol
CASRN 22203-98-1
Amount 50 mg
Category
Type Inhibitors
Specific against other
Smiles O=C(NC=1C=CC=C(Cl)C1)C2=CC(Cl)=CC=C2O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 3',5-Dichlorosalicylanilide
Available
Short Description
SARS-CoV-2-IN-14 is a potent and oral inhibitor of SARS-CoV-2 (IC50:0.39 μM), which is an analogue of niclosamide. SARS-CoV-2-IN-14 was more stable than niclosamide in the determination of human plasma and liver S9 enzyme. Oral administration of SARS-CoV-2-IN-14 can improve its bioavailability and half-life.
Shipping
cool pack
Storage
-20°
Target names or alias
3', 5-Dichlorosalicylanilide
Molecular Weight
282, 12
Pathway
Microbiology/Virology
Target
SARS-CoV

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close